 | Up a level |
Journal Article
Fritsch, K., Kasenda, B., Schorb, E., Hau, P., Bloehdorn, J., Moehle, R., Loew, S., Binder, M., Atta, J., Keller, U., Wolf, H-H, Krause, S. W., Hess, G., Naumann, R., Sasse, S., Hirt, C., Lamprecht, M., Martens, U., Morgner, A., Panse, J., Frickhofen, N., Roeth, A., Hader, C., Deckert, M., Fricker, H., Ihorst, G., Finke, J. and Illerhaus, G. (2017). High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). Leukemia, 31 (4). S. 846 - 853. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Herrlinger, U., Schaefer, N., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Leutgeb, B., Urbach, H., Stummer, W. and Glas, M. (2014). THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Kebir, S., Schaefer, N., Hattingen, E., Steinbach, J., Weyerbrock, A., Hau, P., Goldbrunner, R., Proescholdt, M., Herrlinger, U. and Glas, M. (2017). EFFECT OF AGE ON OUTCOME IN THE GLARIUS TRIAL. Neuro-Oncology, 19. S. 74 - 75. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Kebir, S., Stummer, W., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Proescholdt, M., Vatter, H., Herrlinger, U. and Glas, M. (2017). COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA. RESULTS FROM THE GLARIUS TRIAL. Neuro-Oncology, 19. S. 112 - 113. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866